The audit-prep handoff moment
Picture the RA/QA manager in an audit-prep handoff before an inspector asks about external data. Internal complaints are organized, but public signals are not yet connected to owners, review cadence, or record destinations.
The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to map external source families, internal record paths, and qualified-review decisions.
External PMS monitoring checklist
| Checklist row | Question to answer |
|---|---|
| Source family | Which regulator, recall, safety-alert, literature, distributor, or field source is monitored? |
| Signal threshold | When does the item become monitor-only context, comparator context, or a product-specific question? |
| Internal destination | Which complaint, CAPA, risk, PMS, supplier, service, or management-review file receives the note? |
| Owner and cadence | Who checks the source, how often, and who reviews escalation? |
| Boundary | Which conclusions remain outside the external monitoring checklist? |
What good looks like
The result should be a repeatable external PMS source map. It should show source checked, date checked, signal found, internal destination, owner, cadence, and open review questions.
A useful source map does not turn public signals into company-specific conclusions. It makes the monitoring workflow testable.
Source ledger
What it can tell you
Public FDA recall and early-alert records that can feed external PMS monitoring.
What it cannot decide
Whether one signal applies to a specific product, complaint file, CAPA screen, reportability review, or risk file.
What it can tell you
Canadian public recall and safety-alert records that may be part of an external PMS source checklist.
What it cannot decide
Whether a manufacturer, importer, or distributor has met Canadian postmarket obligations for one product.
What it can tell you
European medical-device sector resources and public context that can frame EU postmarket evidence questions.
What it cannot decide
Whether one company's PMS, PMCF, vigilance, clinical, or conformity evidence is sufficient.
Frequently asked questions
Does external PMS mean outsourcing postmarket decisions?
No. External PMS organizes outside source checks and signal routing. Product-specific decisions remain with qualified company reviewers.
What is the first useful output?
An external PMS monitoring checklist with source families, signal thresholds, internal record destinations, owners, cadence, and open review questions.
Need external PMS sources turned into a monitoring checklist?
Send the product family, markets, and current source list. We can scope a source-backed external PMS checklist for qualified review.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.